Response to third rubella vaccine dose

References

• World Health Organization. Eliminating measles and rubella: Framework for the verification process in the WHO European Region, http://www.euro.who.int/__data/assets/pdf_file/0009/247356/Eliminating-measles-and-rubella-Framework-for-the-verification-process-in-the-WHO-European-Region.pdf. 2014.
   Google Scholar
• Orenstein WA, Hinman A, Nkowane B, Olive JM, Reingold A. Measles and Rubella Global Strategic Plan 2012–2020 midterm review. Vaccine. 2018;36 Suppl 1:A1–A34. doi:10.1016/j.vaccine.2017.09.026. PMID:29307367.
   PubMedGoogle Scholar
• Norwegian Surveillance System for Communicable Diseases (MSIS). http://www.msis.no/ Accessed 12 January, 2018.
   Google Scholar
• World Health Organization Regional Office for Europe. Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC). 2016.
   Google Scholar
• Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950–6. doi:10.1086/528993. PMID:18419470.
   PubMed Web of Science ®Google Scholar
• WHO vaccine-preventable diseases monitoring system 2017 global summary. http://apps.who.int/immunization_monitoring/globalsummary/schedules Accessed 12 January, 2018.
   Google Scholar
• Dimech W, Mulders MN. A 16-year review of seroprevalence studies on measles and rubella. Vaccine. 2016;34:4110–8. doi:10.1016/j.vaccine.2016.06.002. PMID:27340097.
   PubMed Web of Science ®Google Scholar
• Vainio K, Samdal HH, Anestad G, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge I. Seroprevalence of measles among Norwegian military conscripts in 2004. Eur J Clin Microbiol Infect Dis. 2007;26:217–20. doi:10.1007/s10096-007-0258-8. PMID:17273828.
   PubMed Web of Science ®Google Scholar
• Flugsrud LB, Rld TO, Aasen S, Berdal BP. Measles antibodies and herd immunity in 20- and 40-year-old Norwegians. Scand J Infect Dis. 1997;29:137–40 doi:10.3109/00365549709035873. PMID:9181648.
   PubMed Web of Science ®Google Scholar
• Nardone A, Tischer A, Andrews N, Backhouse J, Theeten H, Gatcheva N, Zarvou M, Kriz B, Pebody RG, Bartha K, O'Flanagan D, Cohen D, Duks A, Griskevicius A, Mossong J, Barbara C, Pistol A, Slacikova M, Prosenc K, Johansen K, Miller E. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ. 2008;86:118–25 doi:10.2471/BLT.07.042010. PMID:18297166.
   PubMed Web of Science ®Google Scholar
• Løvoll Ø, Sandbu S. Measles and measles immunisation in Norway: historical review and present situation. Eurosurveillance. 2002;6:2099.
   Google Scholar
• Norwegian Immunisation Registry (SYSVAK). http://www.norgeshelsa.no/. Accessed 11 January, 2018.
   Google Scholar
• Hagerup-Jenssen M, Kongsrud S, Riise OR. Suboptimal MMR2 vaccine coverage in six counties in Norway detected through the national immunisation registry, April 2014to April 2017. Eurosurveillance. 2017;22:30518. doi:10.2807/1560-7917.ES.2017.22.17.30518.
   Google Scholar
• Vainio K, Samdal HH, Anestad G, Wedege E, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge IS. Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. Eur J Clin Microbiol Infect Dis. 2008;27:461–5. doi:10.1007/s10096-008-0460-3. PMID:18293018.
   PubMed Web of Science ®Google Scholar
• Hui SYA, Sahota DS, Lao TT. Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger. PLoS One. 2017;12:e0183630. doi:10.1371/journal.pone.0183630. PMID:28854204.
   PubMed Web of Science ®Google Scholar
• Barlinn R, Vainio K, Samdal HH, Nordbo SA, Nokleby H, Dudman SG. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014;86:820–6. doi:10.1002/jmv.23757. PMID:24114849.
   PubMed Web of Science ®Google Scholar
• Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, Jaipaul J, Tipples GA, Charlton CL. Determining rubella immunity in pregnant Alberta women 2009–2012. Vaccine. 2015;33:635–41. doi:10.1016/j.vaccine.2014.12.022. PMID:25533327.
   PubMed Web of Science ®Google Scholar
• Gilbert NL, Rotondo J, Shapiro J, Sherrard L, Fraser WD, Ward BJ. Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011. Vaccine. 2017;35:3050–5. doi:10.1016/j.vaccine.2017.04.057. PMID:28461066.
   PubMed Web of Science ®Google Scholar
• Barlinn R, Dudman S, Riise Ø, Nøkleby H. Immunitet mot rubella (røde hunder) – en litteraturgjennomgang med anbefalinger https://www.fhi.no/publ/2016/immunitet-mot-rode-hunder/Folkehelseinstituttet. 2016; ISBN 978-82-8082-5.
   Google Scholar
• Kakoulidou M, Forsgren M, Lewensohn-Fuchs I, Johansen K. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Vaccine. 2010;28:1002–7. doi:10.1016/j.vaccine.2009.10.130. PMID:19925909.
   PubMed Web of Science ®Google Scholar
• Levine H, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Zarka S, Balicer RD. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel. Vaccine. 2012;30:7260–4. doi:10.1016/j.vaccine.2012.09.075. PMID:23063839.
   PubMed Web of Science ®Google Scholar
• Byrne L, Brant L, Reynolds C, Ramsay M. Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004–2009. Is rubella susceptibility increasing? Vaccine. 2012;30:161–7. PMID:22119593.
   PubMed Web of Science ®Google Scholar
• Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168:148–55. doi:10.1001/jamapediatrics.2013.4342. PMID:24311021.
   PubMed Web of Science ®Google Scholar
• Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol. 1996;106:170–4 doi:10.1093/ajcp/106.2.170. PMID:8712168.
   PubMed Web of Science ®Google Scholar
• Serena GM, Filomena GM, Vittoria LA, Cinzia G, Silvio T. Lack of immunity against rubella among Italian young adults. BMC Infect Dis. 2017;17:199. doi:10.1186/s12879-017-2295-y. PMID:28270106.
   PubMed Web of Science ®Google Scholar
• Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Clin Immunol. 2005;115:154–61. doi:10.1016/j.clim.2004.12.010. PMID:15885638.
   PubMed Web of Science ®Google Scholar
• Honeyman MC, Forrest JM, Dorman DC. Cell-mediated immune response following natural rubella and rubella vaccination. Clin Exp Immunol. 1974;17:665–71. PMID:4619795.
   PubMed Web of Science ®Google Scholar
• Bouthry E, Furione M, Huzly D, Ogee-Nwankwo A, Hao L, Adebayo A, Icenogle J, Sarasini A, Revello MG, Grangeot-Keros L, Vauloup-Fellous C. Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays. J Clin Microbiol. 2016;54:1720–5. doi:10.1128/JCM.00383-16. PMID:27147722.
   PubMed Web of Science ®Google Scholar
• Rosa-Fraile M, Sampedro A, Rodriguez-Granger J, Camacho E, Manrique E. Suitability of frozen serum stored in gel separator primary sampling tubes for serological testing. Clin Diagn Lab Immunol. 2004;11:219–21. PMID:14715572.
   PubMedGoogle Scholar
• Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect. 2004;132:11–8 doi:10.1017/S0950268803001584. PMID:14979584.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Escalada A, Garcia-Garcia L, Viguera-Ester P, Marin-Garcia P, Garcia J, Gil-de-Miguel A, Gil-Prieto R. Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid Spain. Hum Vaccin Immunother. 2013;9:1918–25. doi:10.4161/hv.25127.
   PubMed Web of Science ®Google Scholar
• Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109:9–15. doi:10.1093/trstmh/tru167. PMID:25573105.
   PubMed Web of Science ®Google Scholar
• Vauloup-Fellous C, Grangeot-Keros L. Humoral immune response after primary rubella virus infection and after vaccination. Clin Vaccine Immunol. 2007;14:644–7. doi:10.1128/CVI.00032-07. PMID:17344342.
   PubMed Web of Science ®Google Scholar